SEC Form 4 · accession 0001104659-15-050977
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas J. Lowery
Officer — Chief Scientific Officer
Period of report
Jul 10, 2015
Accepted (ET)
Jul 14, 2015 · 11:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2015 | M | 2,000 | $1.31 | A | 6,411 | D | |
| Common Stock | Jul 10, 2015 | S | 2,000 | $16.03 | D | 4,411 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.31 | Jul 10, 2015 | M | 2,000 | D | Feb 5, 2014 | Feb 5, 2020 | Common Stock | 2,000 | 18,588 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2015.